drugset / Trial / NCT04147182

Perioperative Intravesical Instilation of Hypertonic Saline Following Bladder Tumor Resection

NCT04147182

Phase 1 Unknown 15 enrolled Dan Leibovici
NaSingle-groupOpen-labelTreatment

Summary

Hypertonic saline at the concentration of 3% (hypersel) has been injected for years into echinococcal cysts to kill live scolices, and is also known to kill suspended cells by means of a steep osmotic gradient and the investigators postulate that perioperative intravesical instillation of hypersel for patients with low grade bladder cancer is safe and may be active against shedded and suspended tumor cells and thus may decrease recurrence risk.

Timeline

Start
2018-12-02
Primary completion
2019-07-03
Completion
2020-11-03

Drugs

EvaluationDrugModalityDoseRoute
Subject sodium chloride Unknown 3 % Other

Indications

No indication recorded.